Skip to main content
. 2021 Jun 16;8:664626. doi: 10.3389/fcvm.2021.664626

Figure 2.

Figure 2

Cardiac fibroblast-specific PGC-1αKO aggravates cardiac hypertrophy. (A) Quantitative analysis of the ratio of the weight of mouse heart to body weight. (B) Representative cross sections of the heart stained for Masson and WGA. Quantitative analysis of the thickness of ventricular wall (Masson staining) and cardiomyocyte size (WGA staining). (C) qPCR analysis of mRNA expression levels of hypertrophic markers (ANP, BNP, Gata4, βMHC). N.S. indicates no significant difference. *p < 0.05, **p < 0.01. Data represent mean ± SEM (n = 5 per group).